Table 3.
Mendelian randomization on the effect of cg05575921 on coronary artery disease (CAD), cIMT and stroke
Method | Estimate (95% CI) | p value | p value heterogeneity (IVW) |
---|---|---|---|
cg05575921 → CAD | |||
IVW | 0.5 (− 0.03 to 0.9) | 0.06 | 0.8 |
cg05575921 → cIMT (mm) | |||
IVW | 0.06 (0.01–0.1) | 0.01 | 0.2 |
MR-Egger | − 0.04 (− 0.2 to 0.09) | 0.5 | – |
MR-Egger (intercept) | 0.003 | 0.1 | – |
Weighted median | 0.07 (0.008–0.13) | 0.02 | – |
cg05575921 → Stroke | |||
IVW | 0.8 (0.23–1.47) | 0.007 | 0.8 |
MR-Egger | 0.3 (− 1.3–1.9) | 0.7 | – |
MR-Egger (intercept) | 0.02 | 0.5 | – |
Weighted median | 0.9 (0.17–1.58) | 0.01 | – |